C4ORF46 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.599800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.399600E-01
Normal-vs-Stage2
2.312600E-01
Normal-vs-Stage3
2.508200E-01
Normal-vs-Stage4
3.346200E-01
Stage1-vs-Stage2
8.100000E-01
Stage1-vs-Stage3
6.213600E-01
Stage1-vs-Stage4
8.022400E-01
Stage2-vs-Stage3
6.808600E-01
Stage2-vs-Stage4
9.103800E-01
Stage3-vs-Stage4
8.600400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.944000E-01
Normal-vs-AfricanAmerican
1.386380E-01
Normal-vs-Asian
6.668400E-02
Caucasian-vs-AfricanAmerican
8.146600E-01
Caucasian-vs-Asian
3.331400E-01
AfricanAmerican-vs-Asian
5.395000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.339400E-01
Normal-vs-Female
4.127000E-01
Male-vs-Female
2.968000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.584300E-02
Normal-vs-Age(41-60Yrs)
6.190000E-01
Normal-vs-Age(61-80Yrs)
2.806800E-01
Normal-vs-Age(81-100Yrs)
1.379970E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.505200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.981400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.321000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.348200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.460200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.387400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.878300E-02
Normal-vs-Daily Drinker
3.892000E-01
Normal-vs-Weekly Drinker
5.330800E-01
Normal-vs-Occasional Drinker
2.068800E-01
Normal-vs-Social Drinker
7.982000E-01
Non Drinker-vs-Daily Drinker
3.771600E-01
Non Drinker-vs-Weekly Drinker
3.613600E-01
Non Drinker-vs-Occasional Drinker
3.098600E-01
Non Drinker-vs-Social Drinker
8.316200E-02
Daily Drinker-vs-Weekly Drinker
8.082400E-01
Daily Drinker-vs-Occasional Drinker
9.388600E-01
Daily Drinker-vs-Social Drinker
2.623800E-01
Weekly Drinker-vs-Occasional Drinker
7.381800E-01
Weekly Drinker-vs-Social Drinker
4.575600E-01
Occasional Drinker-vs-Social Drinker
2.375600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.653800E-01
Normal-vs-Grade 2
7.813000E-01
Normal-vs-Grade 3
7.915600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.013600E-01
Grade 1-vs-Grade 3
6.186400E-01
Grade 1-vs-Grade 4
5.653800E-01
Grade 2-vs-Grade 3
6.806800E-01
Grade 2-vs-Grade 4
7.813000E-01
Grade 3-vs-Grade 4
7.915600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.339600E-02
Normal-vs-NonDiabetic
4.543200E-01
Diabetic-vs-NonDiabetic
1.489160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.848080E-02
Normal-vs-NoPancreatitis
3.632400E-01
Pancreatitis-vs-NoPancreatitis
2.554800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.314000E-02
Normal-vs-N1
2.573400E-01
N0-vs-N1
4.859600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.470600E-01
Normal-vs-TP53-NonMutant
6.966600E-01
TP53-Mutant-vs-TP53-NonMutant
8.914800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
